Detalhe da pesquisa
1.
Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends. / Vigilancia epidemiológica en los últimos 4 años del Registro Español de Investigación en Dermatitis de Contacto y Alergia Cutánea: situación actual y tendencias.
Actas Dermosifiliogr
; 115(4): 331-340, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38061453
2.
[Translated article] Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends.
Actas Dermosifiliogr
; 115(4): T331-T340, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38331170
3.
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). / Supervivencia de la ciclosporina en el tratamiento de la dermatitis atópica moderada-grave: Registro Español de Dermatitis Atópica (BIOBADATOP).
Actas Dermosifiliogr
; 115(4): 341-346, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-37482292
4.
Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC). / Perfil epidemiológico, clínico y alérgico en pacientes con psoriasis. Evaluación del Registro Español de Dermatitis de Contacto (REIDAC).
Actas Dermosifiliogr
; 2024 Feb 19.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38382750
5.
[Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).
Actas Dermosifiliogr
; 2024 Apr 20.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38648935
6.
[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Actas Dermosifiliogr
; 115(4): T341-T346, 2024 Apr.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38325545
7.
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). / Actualización de la batería estándar y batería ampliada de pruebas alérgicas de contacto por el Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC).
Actas Dermosifiliogr
; 2024 Mar 29.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-38556197
8.
Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.
J Eur Acad Dermatol Venereol
; 37(7): 1396-1405, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-36950901
9.
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings. / BIOBADATOP: Registro Español de Dermatitis Atópica. Descripción y primeros resultados.
Actas Dermosifiliogr
; 114(6): 479-487, 2023 Jun.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-36935039
10.
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
Br J Dermatol
; 186(1): 142-152, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34254291
11.
Consensus on the Definition of Control and Remission in Chronic Urticaria.
J Investig Allergol Clin Immunol
; 32(4): 261-269, 2022 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35503509
12.
Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices.
J Eur Acad Dermatol Venereol
; 35(7): 1444-1448, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33955077
13.
Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
J Investig Allergol Clin Immunol
; 29(5): 338-348, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30222111
14.
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Allergy
; 72(4): 519-533, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27861988
15.
New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?
J Eur Acad Dermatol Venereol
; 36(2): e80-e81, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34547146
16.
Contact allergy to preservatives: ESSCA* results with the baseline series, 2009-2012.
J Eur Acad Dermatol Venereol
; 31(4): 664-671, 2017 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27896884
17.
Minimum standards on prevention, diagnosis and treatment of occupational and work-related skin diseases in Europe - position paper of the COST Action StanDerm (TD 1206).
J Eur Acad Dermatol Venereol
; 31 Suppl 4: 31-43, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28656728
18.
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
Br J Dermatol
; 184(1): 167-168, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32730636
19.
Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of Methylisothiazolinone (MI) (P94), in cosmetic products (sensitisation only).
Regul Toxicol Pharmacol
; 76: 211-2, 2016 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26790577
20.
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.
J Eur Acad Dermatol Venereol
; 30 Suppl 5: 25-32, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27286500